A carregar...
Serum free IgE guided dose reduction of omalizumab: a case report
BACKGROUND: Omalizumab is a human IgG1 antibody against IgE used as a therapy for sever asthmatic patients with asthma. According to the guidelines of the Global Initiative for Asthma, omalizumab is an add-on drug at treatment step 5 that is used for severe asthma patients who are allergic to perenn...
Na minha lista:
| Publicado no: | Allergy Asthma Clin Immunol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5577842/ https://ncbi.nlm.nih.gov/pubmed/28861109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13223-017-0211-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|